[1] Pati S, Irfan W, Jameel A, Ahmed S, Shahid RK. Obesity and cancer: a current overview of epidemiology, pathogenesis, outcomes, and management. Cancers (Basel) 2023;15(2):485.
[2] Ahmed B, Sultana R, Greene MW. Adipose tissue and insulin resistance in obese. Biomed Pharmacother 2021;137:111315.
[3] Pan XF, Wang LM, Pan A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol 2021;9(6):373 − 92.
[4] Han BF, Zheng RS, Zeng HM, Wang SM, Sun KX, Chen R, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Center 2024;4(1):47 − 53.
[5] Safizadeh F, Mandic M, Schöttker B, Hoffmeister M, Brenner H. Central obesity may account for most of the colorectal cancer risk linked to obesity: evidence from the UK Biobank prospective cohort. Int J Obes 2025;49(4):619 − 26.
[6] Lin Y, Yang Y, Li Z. Cohort profile: the West-China hospital alliance longitudinal epidemiology wellness (WHALE) study. Eur J Epidemiol 2025. http://dx.doi.org/10.1007/s10654-025-01290-1.
[7] Lennon H, Sperrin M, Badrick E, Renehan AG. The obesity paradox in cancer: a review. Curr Oncol Rep 2016;18(9):56.
[8] Rask-Andersen M, Ivansson E, Höglund J, Ek WE, Karlsson T, Johansson Å. Adiposity and sex-specific cancer risk. Cancer Cell 2023;41(6):1186 − 97.e4.
[9] Wang MY, Wen CP, Pan JL, Sun GG, Chu DTW, Tu HK, et al. Chinese visceral adiposity index outperforms other obesity indexes in association with increased overall cancer incidence: findings from prospective MJ cohort study. Br J Cancer 2025;133(2):227 − 38.
[10] Wang SY, Zhang WS, Jiang CQ, Jin YL, Zhu T, Zhu F, et al. Association of novel and conventional obesity indices with colorectal cancer risk in older Chinese: a 14-year follow-up of the Guangzhou Biobank Cohort Study. BMC Cancer 2023;23(1):286.
[11] Liu XZ, Pedersen L, Halberg N. Cellular mechanisms linking cancers to obesity. Cell Stress 2021;5(5):55 − 72.
[12] Wang QL, Babic A, Rosenthal MH, Lee AA, Zhang Y, Zhang XH, et al. Cancer diagnoses after recent weight loss. JAMA 2024;331(4):318 − 28.